Drugs News and Research

RSS

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.

29 Apr 2021

New method could be used to develop more effective treatments for cancer, metabolic disorders

Researchers from the University of Copenhagen have developed a new method that makes it possible to control human hormones and metabolism.

28 Apr 2021

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

Being transparent about the results of completed clinical trials enables important advances in the development of medical products and helps ensure a safe, effective and efficient clinical research enterprise.

28 Apr 2021

Young people of color with a higher income more likely to participate in cancer clinical trials

People of color, those with a higher income and younger individuals are more likely to participate in clinical trials during their cancer treatment according to a new study from the University of Missouri School of Medicine.

28 Apr 2021

Mutation in a cancer-causing gene could exacerbate cerebral cavernous malformations in the brain

Researchers have discovered an explanation for why cerebral cavernous malformations (CCMs)--clusters of dilated blood vessels in the brain--can suddenly grow to cause seizures or stroke.

28 Apr 2021

Study explores link between text anxiety and poor sleep

College students across the country struggle with a vicious cycle: Test anxiety triggers poor sleep, which in turn reduces performance on the tests that caused the anxiety in the first place.

28 Apr 2021

Topical therapy can help safely reduce side effect of cancer treatment

Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

28 Apr 2021

Intramuscular droperidol more effective than other drugs for treatment of acute agitation in the ED

In a randomized, double-blind trial of patients with acute undifferentiated agitation in the emergency department, droperidol was more effective for sedation and was associated with fewer episodes of respiratory depression than lorazepam or either dose of ziprasidone.

28 Apr 2021

Study reveals the role of lncRNAs in immune dysfunction during severe COVID-19

Scientific studies rarely focus on long non-coding RNA molecules (lncRNAs), even though they potentially regulate several diseases. The role of several lncRNAs in anti-viral inflammatory response regulation has recently been reported.

28 Apr 2021

Scientists gain atomic-level insight into behavior of a protein that promotes cancer growth

The neutron reflexometry method has given scientists an atomic-level insight into the behavior of Bcl-2, a protein that promotes cancerous cell growth. The new study was carried out by Umeå chemists in collaboration with the research facilities ESS and ISIS and is published in Nature Communications Biology.

28 Apr 2021

Regular exercise improves vascular function in patients with autoimmune rheumatic diseases

The risk of developing atherosclerosis - a narrowing of the arteries as cholesterol plaque builds up, leading to obstruction of blood flow - is higher for people with autoimmune rheumatic diseases than for the general population.

27 Apr 2021

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.

27 Apr 2021

New treatment reduces the severity of ARDS in influenza-infected mice

A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.

27 Apr 2021

Cholestenone could be a new antibacterial drug against H. pylori

Helicobacter pylori (H. pylori), a gram-negative pathogen that has infected half of the world's population is a Group I carcinogen according to the WHO. H. pylori resides in the gastric mucosa causing gastritis, ulcers, gastric cancers and malignant lymphoma of the stomach.

27 Apr 2021

NUS study identifies protein that could be targeted to overcome chemoresistance in cancer

Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cancer cells in the body. It is a systemic treatment where drugs travel throughout the body and destroy cancer cells that have spread (metastasized) to parts of the body far away from the original (primary) tumor.

27 Apr 2021

Drugs News and Research

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

New method could be used to develop more effective treatments for cancer, metabolic disorders

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

Young people of color with a higher income more likely to participate in cancer clinical trials

Mutation in a cancer-causing gene could exacerbate cerebral cavernous malformations in the brain

Study explores link between text anxiety and poor sleep

Topical therapy can help safely reduce side effect of cancer treatment

Intramuscular droperidol more effective than other drugs for treatment of acute agitation in the ED

Study reveals the role of lncRNAs in immune dysfunction during severe COVID-19

Scientists gain atomic-level insight into behavior of a protein that promotes cancer growth

Regular exercise improves vascular function in patients with autoimmune rheumatic diseases

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

New treatment reduces the severity of ARDS in influenza-infected mice

Cholestenone could be a new antibacterial drug against H. pylori

NUS study identifies protein that could be targeted to overcome chemoresistance in cancer

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Some heart medications may facilitate SARS-CoV-2 infection through increasing ACE2 receptor levels

What is the role of nanotechnology in the current COVID-19 outbreak?

New AI-driven diagnostics technique could transform treatment for bowel cancer

Prolactin hormone acts as a major contributor to breast cancer development, studies find

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News